Spreadsheet: 2f5fa430-916c-4a64-b009-69d54968df26
Sheet: Sheet1

Unnamed: 0 | Table S2: Genes down-regulated by spaceflight (vs. ground control) | Unnamed: 2 | Unnamed: 3
Probe No. | Accession No. | [NAME] | SF/GC
MmEG-0037 | NM_011851 | 5' nucleotidase, ecto (Nt5e), mRNA | 0.33
MmEG-0053 | NM_007399 | a disintegrin and metallopeptidase domain 10 (Adam10), mRNA | 0.47
MmEG-0091 | NM_009716 | activating transcription factor 4 (Atf4), mRNA | 0.45
MmEG-0095 | NM_053178 | acyl-CoA synthetase bubblegum family member 1 (Acsbg1), mRNA | 0.43
MmEG-0128 | NM_012054 | acyloxyacyl hydrolase ([NAME]), mRNA | 0.29
MmEG-0160 | NM_013462 | adrenergic receptor, beta 3 (Adrb3), mRNA | 0.32
MmEG-0268 | NM_009692 | apolipoprotein A-I (Apoa1), mRNA | 0.19
MmEG-0340 | NM_016774 | ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit (Atp5b), nuclear gene encoding mitochondrial protein, mRNA | 0.43
MmEG-0342 | NM_020615 | ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 (Atp5c1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA | 0.49
MmEG-0344 | [NAME] | ATPase family, AAA domain containing 2 (Atad2), mRNA | 0.3
MmEG-0368 | NM_144900 | ATPase, Na+/K+ transporting, alpha 1 polypeptide (Atp1a1), mRNA | 0.42
MmEG-0397 | NM_009646 | autoimmune regulator (autoimmune polyendocrinopathy candidiasis ectodermal dystrophy) (Aire), mRNA | 0.46
MmEG-0444 | NM_009735 | [NAME] (B2m), mRNA | 0.46
MmEG-0468 | NM_007553 | bone morphogenetic protein 2 (Bmp2), mRNA | 0.42
MmEG-0481 | NM_018819 | brain protein 44-like (Brp44l), mRNA | 0.42
MmEG-0513 | NM_009788 | calbindin 1 (Calb1), mRNA | 0.45
MmEG-0532 | NM_009795 | calpain, small subunit 1 (Capns1), mRNA | 0.47
MmEG-0557 | NM_009801 | carbonic anhydrase 2 (Car2), mRNA | 0.46
MmEG-0563 | NM_007592 | carbonic anhydrase 8 (Car8), mRNA | 0.26
MmEG-0676 | NM_133655 | CD81 antigen (Cd81), mRNA | 0.47
MmEG-0725 | NM_007684 | centrin 3 (Cetn3), mRNA | 0.46
MmEG-0729 | NM_145475 | ceramide kinase ([NAME]), mRNA | 0.38
MmEG-0921 | NM_021273 | [NAME], brain (Ckb), mRNA | 0.44
MmEG-0978 | NM_007635 | cyclin G2 (Ccng2), mRNA | 0.46
MmEG-0980 | NM_017367 | cyclin I (Ccni), mRNA | 0.45
MmEG-1036 | [NAME] | cytochrome c oxidase subunit IV isoform 1 (Cox4i1), mRNA | 0.48
MmEG-1044 | NM_009945 | cytochrome c oxidase, subunit VIIa 2 (Cox7a2), mRNA | 0.49
MmEG-1048 | NM_025567 | cytochrome c-1 (Cyc1), mRNA | 0.45
MmEG-1122 | NM_011873 | DAZ associated protein 2 (Dazap2), mRNA | 0.49
MmEG-1149 | NM_007853 | [NAME] homolog 1 (Drosophila) (Degs1), mRNA | 0.4
MmEG-1166 | NM_009345 | deoxynucleotidyltransferase, terminal ([NAME]), transcript variant 1, mRNA | 0.43
MmEG-1168 | NM_019957 | deoxyribonuclease II beta (Dnase2b), mRNA | 0.49
MmEG-1179 | NM_007830 | diazepam binding inhibitor ([NAME]), transcript variant 2, mRNA | 0.41
MmEG-1221 | NM_007875 | dolichyl-phosphate (UDP-N-acetylglucosamine) acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) (Dpagt1), mRNA | 0.42
MmEG-1272 | NM_021876 | [NAME] ectoderm development ([NAME]), mRNA | 0.49
MmEG-1293 | NM_026728 | enoyl Coenzyme A hydratase domain containing 2 (Echdc2), mRNA | 0.38
MmEG-1334 | NM_007907 | eukaryotic translation elongation factor 2 (Eef2), mRNA | 0.46
MmEG-1371 | NM_010166 | eyes absent 3 homolog (Drosophila) (Eya3), transcript variant 2, mRNA | 0.44
MmEG-1381 | NM_134469 | farnesyl diphosphate synthetase (Fdps), mRNA | 0.48
MmEG-1395 | NM_021272 | fatty acid binding protein 7, brain (Fabp7), mRNA | 0.45
MmEG-1399 | NM_010234 | FBJ osteosarcoma oncogene (Fos), mRNA | 0.4
MmEG-1462 | NM_008593 | forkhead [NAME] (Foxd2), mRNA | 0.41
MmEG-1483 | NM_019395 | fructose bisphosphatase 1 (Fbp1), mRNA | 0.4
MmEG-1489 | NM_025799 | fucosidase, alpha-L- 2, plasma (Fuca2), mRNA | 0.38
MmEG-1533 | NM_010250 | gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1 (Gabra1), mRNA | 0.45
MmEG-1592 | NM_008129 | glutamate-cysteine ligase, modifier subunit (Gclm), mRNA | 0.49
MmEG-1716 | NM_012015 | H2A histone family, member Y (H2afy), transcript variant 1, mRNA | 0.45
MmEG-1718 | NM_008210 | H3 histone, family 3A (H3f3a), mRNA | 0.49
MmEG-1742 | NM_010480 | heat shock protein 90, alpha (cytosolic), class A member 1 (Hsp90aa1), mRNA | 0.47
MmEG-1868 | NM_008321 | inhibitor of DNA binding 3 (Id3), mRNA | 0.42
MmEG-2011 | NM_008365 | interleukin 18 receptor 1 (Il18r1), transcript variant 1, mRNA | 0.43
MmEG-2065 | NM_130884 | isocitrate dehydrogenase 3 (NAD+) beta (Idh3b), nuclear gene encoding mitochondrial protein, mRNA | 0.49
MmEG-2103 | NM_011317 | KH domain containing, RNA binding, signal transduction associated 1 (Khdrbs1), mRNA | 0.48
MmEG-2122 | NM_008492 | lactate dehydrogenase B ([NAME]), mRNA | 0.47
MmEG-2149 | NM_024434 | leucine aminopeptidase 3 (Lap3), mRNA | 0.48
MmEG-2178 | [NAME] | lipocalin 5 (Lcn5), transcript variant 1, mRNA | 0.33
MmEG-2218 | NM_053092 | lysyl-tRNA synthetase (Kars), transcript variant 2, mRNA | 0.49
MmEG-2222 | NM_010798 | macrophage migration inhibitory factor (Mif), mRNA | 0.47
MmEG-2235 | NM_008618 | malate dehydrogenase 1, NAD (soluble) (Mdh1), mRNA | 0.41
MmEG-2279 | NM_010808 | matrix metallopeptidase 24 (Mmp24), mRNA | 0.42
MmEG-2323 | NM_133653 | methionine adenosyltransferase I, alpha (Mat1a), mRNA | 0.27
MmEG-2330 | NM_138745 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase (Mthfd1), mRNA | 0.46
MmEG-2368 | NM_025993 | MIS12 homolog (yeast) (Mis12), mRNA | 0.36
MmEG-2370 | NM_026310 | mitochondrial ribosomal protein [NAME] (Mrpl18), nuclear gene encoding mitochondrial protein, mRNA | 0.46
MmEG-2468 | NM_025987 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6 (B14) (Ndufa6), nuclear gene encoding mitochondrial protein, mRNA | 0.46
MmEG-2472 | NM_026061 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8 (Ndufb8), mRNA | 0.48
MmEG-2473 | NM_026684 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10 (Ndufb10), mRNA | 0.44
MmEG-2510 | NM_008675 | neuroblastoma, suppression of tumorigenicity 1 (Nbl1), mRNA | 0.47
MmEG-2515 | NM_010894 | neurogenic differentiation 1 ([NAME]), mRNA | 0.31
MmEG-2526 | NM_008745 | neurotrophic tyrosine kinase, receptor, type 2 (Ntrk2), transcript variant 2, mRNA | 0.49
MmEG-2558 | NM_019730 | non-metastatic cells 3, protein expressed in (Nme3), mRNA | 0.45
MmEG-2602 | NM_008722 | nucleophosmin 1 (Npm1), mRNA | 0.46
MmEG-2652 | NM_011035 | p21 protein (Cdc42/Rac)-activated kinase 1 (Pak1), mRNA | 0.49
MmEG-2659 | NM_011091 | paired-Ig-like receptor A4 (Pira4), mRNA | 0.27
MmEG-2673 | NM_019695 | par-6 (partitioning defective 6,) homolog alpha (C. elegans) (Pard6a), transcript variant 1, mRNA | 0.29
MmEG-2695 | NM_008907 | peptidylprolyl isomerase A (Ppia), mRNA | 0.46
MmEG-2708 | NM_012021 | peroxiredoxin 5 (Prdx5), nuclear gene encoding mitochondrial protein, mRNA | 0.44
MmEG-2771 | NM_023418 | phosphoglycerate mutase 1 (Pgam1), mRNA | 0.49
MmEG-2807 | NM_025939 | [NAME], phosphoribosylaminoribosylaminoimidazole, succinocarboxamide synthetase (Paics), mRNA | 0.49
MmEG-2810 | NM_172783 | phosphorylase kinase alpha 2 (Phka2), mRNA | 0.46
MmEG-2815 | NM_010726 | phytanoyl-CoA hydroxylase (Phyh), mRNA | 0.47
MmEG-2828 | NM_008808 | platelet derived growth factor, alpha (Pdgfa), mRNA | 0.42
MmEG-2852 | NM_021568 | poly(rC) binding protein 3 (Pcbp3), mRNA | 0.35
MmEG-2863 | NM_009085 | polymerase (RNA) I polypeptide C (Polr1c), mRNA | 0.45
MmEG-2870 | NM_019550 | polypyrimidine tract binding protein 2 (Ptbp2), mRNA | 0.48
MmEG-2901 | NM_011170 | prion protein (Prnp), mRNA | 0.49
MmEG-2908 | NM_011072 | profilin 1 (Pfn1), mRNA | 0.37
MmEG-2916 | NM_008831 | [NAME] (Phb), mRNA | 0.42
MmEG-2950 | NM_001029855 | proteasome (prosome, macropain) 28 subunit, beta (Psme2), transcript variant 2, mRNA | 0.41
MmEG-2984 | NM_013636 | protein phosphatase 1, catalytic subunit, gamma isoform (Ppp1cc), mRNA | 0.49
MmEG-3021 | NM_172498 | PTK2 protein tyrosine kinase 2 beta (Ptk2b), transcript variant 3, mRNA | 0.31
MmEG-3023 | NM_008989 | purine rich element binding protein A (Pura), mRNA | 0.44
MmEG-3035 | NM_024221 | pyruvate dehydrogenase (lipoamide) beta (Pdhb), mRNA | 0.48
MmEG-3074 | NM_025654 | RAD52 motif 1 (Rdm1), mRNA | 0.45
MmEG-3094 | NM_009826 | RB1-inducible coiled-coil 1 (Rb1cc1), mRNA | 0.49
MmEG-3187 | NM_009081 | ribosomal protein L28 (Rpl28), mRNA | 0.48
MmEG-3253 | NM_009242 | secreted acidic cysteine rich glycoprotein (Sparc), mRNA | 0.44
MmEG-3260 | NM_009263 | secreted phosphoprotein 1 (Spp1), mRNA | 0.42
MmEG-3284 | NM_010891 | [NAME] ([NAME]), transcript variant 2, mRNA | 0.42
[NAME] | NM_011314 | serum amyloid A 2 (Saa2), mRNA | 0.35
MmEG-3380 | NM_033174 | SNRPN upstream reading frame (Snurf), mRNA | 0.47
MmEG-3382 | NM_148938 | solute carrier family 1 (glial high affinity glutamate transporter), member 3 (Slc1a3), mRNA | 0.46
MmEG-3412 | NM_133668 | solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3 (Slc25a3), nuclear gene encoding mitochondrial protein, mRNA | 0.46
MmEG-3523 | NM_019641 | stathmin 1 (Stmn1), mRNA | 0.49
MmEG-3524 | NM_009133 | stathmin-like 3 (Stmn3), mRNA | 0.49
MmEG-3527 | NM_009128 | stearoyl-Coenzyme A desaturase 2 (Scd2), mRNA | 0.46
MmEG-3539 | [NAME] | sterol regulatory element binding transcription factor 1 (Srebf1), mRNA | 0.48
MmEG-3603 | NM_016807 | syndecan binding protein (Sdcbp), transcript variant 2, mRNA | 0.47
MmEG-3659 | NM_011595 | tissue inhibitor of metalloproteinase 3 (Timp3), mRNA | 0.3
MmEG-3705 | NM_011528 | transaldolase 1 (Taldo1), mRNA | 0.49
MmEG-3717 | NM_133977 | transferrin ([NAME]), mRNA | 0.46
MmEG-3787 | NM_183017 | tubulin tyrosine ligase-like family, member 12 (Ttll12), mRNA | 0.47
MmEG-3836 | NM_031202 | tyrosinase-related protein 1 (Tyrp1), mRNA | 0.38
MmEG-3846 | NM_025407 | ubiquinol-cytochrome c reductase core protein 1 (Uqcrc1), mRNA | 0.49
MmEG-3847 | NM_025710 | ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 (Uqcrfs1), mRNA | 0.46
MmEG-3932 | NM_011701 | [NAME] (Vim), mRNA | 0.34
MmEG-3943 | NM_011695 | voltage-dependent anion channel 2 (Vdac2), mRNA | 0.46
 | SF and GC: spaceflight and ground control.